These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 4614277)
21. Affective disease health maintenance organization. Patterns of lithium response. Shelley EM; Mendlewicz J; Fieve RR N Y State J Med; 1974 Sep; 74(10):1766-8. PubMed ID: 4606182 [No Abstract] [Full Text] [Related]
22. [Clinical study on five depot neuroleptics. Comparison of effective profiles of fluphenazinedecanoate, fluspirilene, penfluridol, perphenazine-enanthate and pipothiazinepalmitate]. Angst J; Woggon B Arzneimittelforschung; 1975 Feb; 25(2):267-70. PubMed ID: 1091272 [TBL] [Abstract][Full Text] [Related]
23. Open trial evaluation of keto-imipramine. Kline NS; Winick L Curr Ther Res Clin Exp; 1971 Jan; 13(1):57-62. PubMed ID: 4992567 [No Abstract] [Full Text] [Related]
24. Combined drug treatment of newly hospitalized, acutely ill psychiatric patients. Hanlon TE; Ota KY; Agallianos DD; Berman SA; Bethon GD; Kobler F; Kurland AA Dis Nerv Syst; 1969 Feb; 30(2):104-16. PubMed ID: 4388249 [No Abstract] [Full Text] [Related]
25. Genetic and clinical factors associated with course in depression. Contributions to genetic aspects. Winokur G Pharmakopsychiatr Neuropsychopharmakol; 1974 Mar; 7(2):122-6. PubMed ID: 4438424 [No Abstract] [Full Text] [Related]
26. [Use of a new butyrophenone in psychiatric service. Outline of a differential study]. Digo R; Karavokyros D; Mlynarski JC Encephale; 1967; 56(1):75-91. PubMed ID: 5340034 [No Abstract] [Full Text] [Related]
27. Ketipramine fumarate as compared to imipramine in depressed outpatients. Park S; Glick B; Floyd A; Gershon S Curr Ther Res Clin Exp; 1971 May; 13(5):322-5. PubMed ID: 4998396 [No Abstract] [Full Text] [Related]
28. The use of lithium in affective disorders. I. Acute endogenous depression. Fieve RR; Platman SR; Plutchik RR Am J Psychiatry; 1968 Oct; 125(4):487-91. PubMed ID: 4886102 [No Abstract] [Full Text] [Related]
29. Thyroid-hormone enhancement of imipramine in nonretarded depressions. Wilson IC; Prange AJ; McClane TK; Rabon AM; Lipton MA N Engl J Med; 1970 May; 282(19):1063-7. PubMed ID: 4908885 [No Abstract] [Full Text] [Related]
36. [The treatment of endogenous depression with monochlorimipramin]. Arnold OH; Heves HP Wien Klin Wochenschr; 1967 Jan; 79(1):3-6. PubMed ID: 5340280 [No Abstract] [Full Text] [Related]
37. [Experience with the use of acrichine in patients in depressive states and catatonis(preliminary report)]. Grudev FI Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(10):1565-71. PubMed ID: 6000321 [No Abstract] [Full Text] [Related]
39. [Comparative characteristics of the effect of melipramine on the bio-electric activity of the brain in patients with circular depression and paranoid schizophrenia]. Burmismrova ZD; Smulevich AB; Faĭgenberg IM Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1375-80. PubMed ID: 5705721 [No Abstract] [Full Text] [Related]
40. Comparable therapeutic efficacy of tryptophan and imipramine: average therapeutic ratings versus "true" equivalence. An important difference. Kline NS; Shah BK Curr Ther Res Clin Exp; 1973 Jul; 15(7):484-7. PubMed ID: 4198311 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]